GCB News

SIX FEET APART, AN EMOTIONAL TOLL

Editor’s note: This is one in a series of first-person essays by members of the Duke community reflecting on a year living with COVID-19.

FERROPTOSIS: AN ARROW INTO THE METABOLIC ACHILLES’ HEEL OF RECURRENT BREAST CANCER

Breast cancer is the second most common cancer among women in the United States. One in eight women will develop the disease. Typically, patients respond well to initial treatment, which usually includes some combination of surgery, radiation, chemotherapy and hormone treatment.

However, some people, even after being in remission for years, can develop recurrent breast cancer tumors, which are often more aggressive and less responsive to the therapies employed in initial cases.

RESEARCH ROUNDUP: FEBRUARY 2021

Here are summaries of a selection of the papers published by GCB faculty in February 2021:

COVID-19

Xiling Shen was part of a team that performed RNA sequencing on whole blood samples from 46 individuals with PCR-positive, symptomatic SARS-CoV-2 infection and compared them directly to subjects with other respiratory infections and healthy controls. Read more

Research Roundup: January 2021

Here are summaries of a selection of the papers published by GCB faculty in January 2021:

EWAS & GWAS

Avshalom Caspi and Terri Moffitt were part of a large team that reported the first large meta-analysis of epigenome-wide association studies of aggressive behavior from over 15,000 people from 18 cohorts. Read more